Trials / Completed
CompletedNCT02414607
Effect of Elderberry Juice on Cognition and Inflammation in Patients With Mild Cognitive Impairment
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University of Missouri-Columbia · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Elderberries (Sambuci fructus) have been shown in a number of studies to have significant anti-inflammatory and antioxidant effects. Multiple human and animal studies have supported the anti-inflammatory and antioxidant effects of elderberry preparations and it has been used in natural medicine for hundreds of years. Studies examining factors that may decrease the risk of Alzheimer's disease have revealed that drinking juices with similar properties to elderberries is one of the most reliable way to decrease risk. As such the investigators wish to determine the effects of elderberry juice on cognitive decline in a group of subjects at high risk for Alzheimer's disease, those with mild cognitive impairment. Elderberry juice is a commercially available nutritional supplement and easily available to this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Elderberry Juice | |
| OTHER | Placebo |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2015-04-13
- Last updated
- 2022-06-23
- Results posted
- 2022-06-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02414607. Inclusion in this directory is not an endorsement.